Contraception News and Research

Latest Contraception News and Research

Some state insurance commissioners push back on Fed premium rate reviews

Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.

7 Jul 2010

BioSante reports positive results from Phase II study of Pill-Plus "triple hormone" oral contraceptive

BioSante Pharmaceuticals, Inc. announced today positive results in a Phase II study of the Pill-Plus "triple hormone" oral contraceptive (OC). Results showed an increase in the frequency of sexual activity (p< 0.05) and reduced frequency of rejection of initiation of sexual activity by partner (p< 0.05).

30 Jun 2010

UPA: An effective non-invasive treatment for fibroids can help maintain fertility in women

A new, effective, non-surgical treatment for uterine fibroids can help women with this condition maintain their fertility, an American scientist told the 26th annual meeting of the European Society of Human Reproduction and Embryology in Rome today (Wednesday).

30 Jun 2010

Better test to predict menopause on the horizon

With the rise of many women delaying when they have a baby until they are older researchers are developing a test that can now tell a woman in her twenties how long she has left to start a family.

28 Jun 2010

Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.

Ferring Pharmaceuticals Inc. announced today the U.S. commercial availability of LYSTEDA™ (tranexamic acid) tablets, the only non-hormonal and non-surgical therapy indicated specifically for the treatment of women with cyclic heavy menstrual bleeding (HMB). In clinical studies, LYSTEDA significantly reduced menstrual blood loss (MBL) over three and six cycles of use with the reduction seen as early as the first cycle of use.

21 Jun 2010

Researchers review data comparing IUDs and hormonal contraceptives

Women who have had intrauterine devices fitted as contraceptives are less likely to become pregnant than those who have hormone injections, a new review by Cochrane Researchers has found. The review, which focused on women in developing countries, also found a possible link between contraceptive method and disease progression in HIV.

19 Jun 2010

Advisory panel recommends FDA approve new "morning after" pill

The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now available over the counter to women 18 and older that gradually loses efficacy after intercourse and can be taken at latest three days after sex.

18 Jun 2010

HRA Pharma announces FDA Advisory Committee approval for ulipristal acetate as emergency contraceptive

HRA Pharma announced today that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive.

18 Jun 2010

Forget play school for infants, sex school proposed in UK health guidelines

National Institute for Health and Clinical Excellence (NICE), UK has come up with its latest health proposal for the improvement of public health. The latest guidance proposal from NICE says sex education should be taught to children from the age of five. This they say is important to help them make the right decisions about delaying sexual intimacy until they are mature enough.

18 Jun 2010

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Today, Bayer HealthCare Pharmaceuticals Inc. and Bayer Schering Pharma AG sued Teva Pharmaceuticals USA, Inc., Barr Pharmaceuticals LLC, and Barr Laboratories, Inc. in the Northern District of Illinois (Chicago) for false advertising and patent infringement in connection with Teva's generic oral contraceptive, Gianvi™. Teva's product is sold as a generic version of Bayer HealthCare's leading oral contraceptive YAZ®.

16 Jun 2010

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.

14 Jun 2010

Increased use of intrauterine devices reduces unwanted pregnancies

A study from the University of Gothenburg, Sweden, which monitored a group of women for 25 years showed that the combined oral contraceptive pill (the pill) is the most common form of contraceptive among women under 29. At the same time many young women have unwanted pregnancies resulting in repeated abortions. According to the researchers increased use of an intrauterine device at a younger age would reduce the number of unwanted pregnancies.

10 Jun 2010

CMAJ to publish comprehensive new guidelines on immigrant health

CMAJ will publish a ground-breaking series of comprehensive new guidelines on immigrant health (pre-embargo link only) beginning June 7, 2010 . The Canadian Immigrant Health Guidelines, a multi-part series, will assist clinicians, policy makers and immigrants in understanding the diverse needs of immigrants to Canada. Few resources like this exist in the international medical literature.

8 Jun 2010

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.

4 Jun 2010

NCHS report: Declines in teen sex, improvements in contraceptive use remain unchanged

Declines in teen sex and improvements in contraceptive use among sexually experienced teens remained essentially unchanged between 2002 and 2006-08, according to data released today by the CDC's National Center for Health Statistics. The new report provides national estimates of sexual activity and contraceptive use among teens aged 15-19 and is based on the latest round of the National Survey of Family Growth.

3 Jun 2010

Advances in women's health, practice of obstetrics and gynaecology to be discussed at SOGC

The 66th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada. Leading international and Canadian experts will meet to discuss the latest knowledge and advances in women's health and in the practice of obstetrics and gynaecology.

29 May 2010

States act on hospital readmissions, brace for insurance rate hikes and advance health legislation

"[M]ore than 200 area hospital administrators, doctors, nurses, and others met with national experts at the Union League in Center City to learn about strategies to reduce hospital readmissions in the five-county Philadelphia area. One approach is to use nurses to proactively treat the highest-risk patients — older people with multiple chronic illnesses — who cost the most money."

28 May 2010

G8 summit recommendations: Funding and resources for maternal, child health must be increased

Governments and other organizations must intensify efforts to improve the health of women and children, particularly in the developing world where the lion's share of deaths occur, says Dr. Philip Baker, an internationally renowned medical researcher in obstetrics & gynecology. Baker is the lead author on a G8 positioning paper that included consultations with 20 of the world's leading medical experts on women and children's health.

27 May 2010

Study shows impact of pregnancy on the life of adolescent women

The effective use of contraception once becoming sexually active is the best way to avoid unwanted pregnancy during adolescence. This is just one of the conclusions of a study by the Spanish National Research Council and the Universidad Complutense in Madrid which additionally reveals that using no contraception or using it well after starting sexual relations increases up to six times the risk for teen pregnancy.

26 May 2010

New study indicates pregnancy can double HIV risk in men

Young women of reproductive-age are among those at greatest risk of acquiring HIV, and several studies have suggested that during pregnancy women are even more susceptible to infection.

24 May 2010

Contraception News and Research

Latest Contraception News and Research

Some state insurance commissioners push back on Fed premium rate reviews

BioSante reports positive results from Phase II study of Pill-Plus "triple hormone" oral contraceptive

UPA: An effective non-invasive treatment for fibroids can help maintain fertility in women

Better test to predict menopause on the horizon

Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.

Researchers review data comparing IUDs and hormonal contraceptives

Advisory panel recommends FDA approve new "morning after" pill

HRA Pharma announces FDA Advisory Committee approval for ulipristal acetate as emergency contraceptive

Forget play school for infants, sex school proposed in UK health guidelines

Bayer sues Teva, Barr in connection with oral contraceptive Gianvi

Agile Therapeutics completes $45 million Series B Preferred Stock financing round

Increased use of intrauterine devices reduces unwanted pregnancies

CMAJ to publish comprehensive new guidelines on immigrant health

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

NCHS report: Declines in teen sex, improvements in contraceptive use remain unchanged

Advances in women's health, practice of obstetrics and gynaecology to be discussed at SOGC

States act on hospital readmissions, brace for insurance rate hikes and advance health legislation

G8 summit recommendations: Funding and resources for maternal, child health must be increased

Study shows impact of pregnancy on the life of adolescent women

New study indicates pregnancy can double HIV risk in men

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in